<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>White papers &#8211; Biomedcode</title>
	<atom:link href="https://www.biomedcode.com/category/white-papers/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.biomedcode.com</link>
	<description>Priming drugs for success</description>
	<lastBuildDate>Mon, 21 Aug 2023 12:34:05 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.biomedcode.com/wp-content/uploads/2019/07/32X32.png</url>
	<title>White papers &#8211; Biomedcode</title>
	<link>https://www.biomedcode.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Tg3647 a slow progressing model of chronic arthritis</title>
		<link>https://www.biomedcode.com/white-papers/tg3647-a-slow-progressing-model-of-chronic-arthritis/</link>
		
		<dc:creator><![CDATA[biomeduser]]></dc:creator>
		<pubDate>Tue, 21 Jan 2020 10:19:18 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[arthritis]]></category>
		<category><![CDATA[preclinical evaluation]]></category>
		<category><![CDATA[slow progression]]></category>
		<guid isPermaLink="false">https://www.biomedcode.com/?p=10711</guid>

					<description><![CDATA[<p>Tg3647 mice over-express human TNF that leads to the gradual development of spontaneous slow progressing chronic inflammatory polyarthritis with 100% penetrance. Histopathological progression of arthritis pathology with age in the Tg3647 model of arthritis &#160; &#160;Download the whitepaper to learn more on: The disease model Study design Routes of administration Validation data Readouts Analysis options &#8230; <a href="https://www.biomedcode.com/white-papers/tg3647-a-slow-progressing-model-of-chronic-arthritis/" class="more-link">Continue reading <span class="screen-reader-text">Tg3647 a slow progressing model of chronic arthritis</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tg3647-a-slow-progressing-model-of-chronic-arthritis/">Tg3647 a slow progressing model of chronic arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #000000;">Tg3647 mice over-express human TNF that leads to the gradual development of spontaneous slow progressing chronic inflammatory polyarthritis with 100% penetrance.</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p><span id="more-10711"></span></p>
<p><img loading="lazy" class="alignnone wp-image-10713 size-large" src="https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-1024x761.jpg" alt="" width="847" height="629" srcset="https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-1024x761.jpg 1024w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-300x223.jpg 300w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-768x571.jpg 768w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-1536x1142.jpg 1536w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG3647-2048x1522.jpg 2048w" sizes="(max-width: 847px) 100vw, 847px" /></p>
<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #999999;">Histopathological progression of arthritis pathology with age in the Tg3647 model of arthritis</span></p>
<p>&nbsp;</p>
</div>
</div>
</div>
</div>
<p><b>&nbsp;</b><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #7e95c5; color: #ffffff;" target="_blank" rel="noopener" href="https://www.biomedcode.com/wp-content/uploads/2019/07/Website2019_Tg3647-white-paper.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tg3647-a-slow-progressing-model-of-chronic-arthritis/">Tg3647 a slow progressing model of chronic arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>CAIA: an induced arthritis model for the efficacy evaluation of arthritis therapeutics</title>
		<link>https://www.biomedcode.com/white-papers/caia-an-induced-arthritis-model-for-the-efficacy-evaluation-of-arthritis-therapeutics/</link>
		
		<dc:creator><![CDATA[biomeduser]]></dc:creator>
		<pubDate>Thu, 16 Jan 2020 10:23:15 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[adalimumab]]></category>
		<category><![CDATA[arthritis]]></category>
		<category><![CDATA[etanercept]]></category>
		<category><![CDATA[induced model]]></category>
		<category><![CDATA[infliximab]]></category>
		<category><![CDATA[preclinical evaluation]]></category>
		<guid isPermaLink="false">https://www.biomedcode.com/?p=10715</guid>

					<description><![CDATA[<p>Collagen antibody-induced arthritis (CAIA) is a simple mouse model of rheumatoid arthritis that can be used to address questions relating to the pathogenic mechanisms of the disease and serves as a platform for the evaluation of candidate therapeutic agents. Biomedcode has standardized the model in C57BL/6 wild type mice, Mice humanized for hTNFR1 Tg1278TNFKO human &#8230; <a href="https://www.biomedcode.com/white-papers/caia-an-induced-arthritis-model-for-the-efficacy-evaluation-of-arthritis-therapeutics/" class="more-link">Continue reading <span class="screen-reader-text">CAIA: an induced arthritis model for the efficacy evaluation of arthritis therapeutics</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/caia-an-induced-arthritis-model-for-the-efficacy-evaluation-of-arthritis-therapeutics/">CAIA: an induced arthritis model for the efficacy evaluation of arthritis therapeutics</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #000000;">Collagen antibody-induced arthritis (CAIA) is a simple mouse model of rheumatoid arthritis that can be used to address questions relating to the pathogenic mechanisms of the disease and serves as a platform for the evaluation of candidate therapeutic agents.</span></p>
<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #000000;">Biomedcode has standardized the model in</span></p>
<ol>
<li><span style="color: #000000;">C57BL/6 wild type mice,</span></li>
<li><span style="color: #000000;">Mice humanized for hTNFR1</span></li>
<li><span style="color: #000000;">Tg1278TNFKO human TNF transgenic mice</span></li>
<li><span style="color: #000000;">Mice humanized for both TNF and TNFR1</span></li>
</ol>
<p><span style="color: #000000;">and developed platforms to allow the evaluation of different arthritis therapeutics.</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p><span id="more-10715"></span></p>
<p><img loading="lazy" class="alignnone wp-image-10712 size-large" src="https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-1024x891.jpg" alt="" width="847" height="737" srcset="https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-1024x891.jpg 1024w, https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-300x261.jpg 300w, https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-768x668.jpg 768w, https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-1536x1336.jpg 1536w, https://www.biomedcode.com/wp-content/uploads/2023/08/CAIA-2048x1781.jpg 2048w" sizes="(max-width: 847px) 100vw, 847px" /></p>
<div class="page" title="Page 2">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #999999;">Representative CAIA in-vivo arthritis progression in Tg1278TNFKO animals treated prophylactically with anti-hTNF therapeutics.</span></p>
</div>
</div>
</div>
</div>
<p>&nbsp;</p>
<p><b>&nbsp;</b></p>
<p><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #7e95c5; color: #ffffff;" target="_blank" rel="noopener" href="https://www.biomedcode.com/wp-content/uploads/2019/08/Website2019_CAIA-white-paper1.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/caia-an-induced-arthritis-model-for-the-efficacy-evaluation-of-arthritis-therapeutics/">CAIA: an induced arthritis model for the efficacy evaluation of arthritis therapeutics</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>TgA86 a mouse model of human spondyloarthritis</title>
		<link>https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-human-spondyloarthritis/</link>
		
		<dc:creator><![CDATA[biomeduser]]></dc:creator>
		<pubDate>Mon, 27 May 2019 10:11:07 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[axial pathology]]></category>
		<category><![CDATA[joint pathology]]></category>
		<category><![CDATA[new bone]]></category>
		<category><![CDATA[preclinical evaluation]]></category>
		<category><![CDATA[spondyloarthritis]]></category>
		<category><![CDATA[transmembrane TNF]]></category>
		<guid isPermaLink="false">https://www.biomedcode.com/?p=10709</guid>

					<description><![CDATA[<p>TgA86 mice overexpress mouse transmembrane TNF from a Δ1-12 mTNF-globin transgene. They develop with 100% incidence peripheral and axial joint pathology accompanied by new bone formation features, all characteristic of human SpA pathology. &#160; Download the whitepaper to learn more on: The disease model Study design Routes of administration Validation data Readouts Analysis options DOWNLOAD &#8230; <a href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-human-spondyloarthritis/" class="more-link">Continue reading <span class="screen-reader-text">TgA86 a mouse model of human spondyloarthritis</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-human-spondyloarthritis/">TgA86 a mouse model of human spondyloarthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<p><span style="color: #000000;">TgA86 mice overexpress mouse transmembrane TNF from a Δ1-12 mTNF-globin transgene. They develop with 100% incidence peripheral and axial joint pathology accompanied by new bone formation features, all characteristic of human SpA pathology.</span></p>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
<p><span id="more-10709"></span></p>
<figure id="attachment_8170" aria-describedby="caption-attachment-8170" style="width: 847px" class="wp-caption alignnone"><img loading="lazy" class="wp-image-8170 size-large" src="https://www.biomedcode.com/wp-content/uploads/2019/04/enbrel-tga86-site-1024x322.jpg" alt="alt text" width="847" height="266"><figcaption id="caption-attachment-8170" class="wp-caption-text"><span style="color: #808080;">Effect of late treatment on the progression of joint (arthritis) and axial (tail) pathology</span></figcaption></figure>
<p><b>&nbsp;</b></p>
<p><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #7e95c5; color: #ffffff;" target="_blank" rel="noopener" href="https://www.biomedcode.com/wp-content/uploads/2019/07/TgA86-white-paper.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-human-spondyloarthritis/">TgA86 a mouse model of human spondyloarthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Tg5453: a mouse model of transmembrane TNF driven arthritis</title>
		<link>https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-spondyloarthritis/</link>
		
		<dc:creator><![CDATA[g y]]></dc:creator>
		<pubDate>Wed, 17 Apr 2019 14:15:53 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[arthritis]]></category>
		<category><![CDATA[preclinical evaluation]]></category>
		<category><![CDATA[transmembrane TNF]]></category>
		<guid isPermaLink="false">http://biomedcodewp.generation-y.net/?p=8362</guid>

					<description><![CDATA[<p>Tg54531 is a transgenic mouse with transmembrane human TNF deregulated expression resulting in the spontaneous development of arthritis pathology that closely resembles human rheumatoid arthritis. The mice develop arthritis with 100% penetrance and provide a fast in-vivo model for evaluating human therapeutics targeting rheumatoid arthritis. The Tg5453 mouse model was successfully used in establishing the &#8230; <a href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-spondyloarthritis/" class="more-link">Continue reading <span class="screen-reader-text">Tg5453: a mouse model of transmembrane TNF driven arthritis</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-spondyloarthritis/">Tg5453: a mouse model of transmembrane TNF driven arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div class="page" title="Page 1">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #000000;">Tg54531 is a transgenic mouse with transmembrane human TNF deregulated expression resulting in the spontaneous development of arthritis pathology that closely resembles human rheumatoid arthritis.</span></p>
<p><span style="color: #000000;">The mice develop arthritis with 100% penetrance and provide a fast in-vivo model for evaluating human therapeutics targeting rheumatoid arthritis.</span></p>
<p><span style="color: #000000;">The Tg5453 mouse model was successfully used in establishing the therapeutic efficacy of Remicade®, the first anti-TNF therapeutic to be successfully applied in the clinic, and is currently used for screening anti-rheumatoid candidate drugs.</span></p>
</div>
</div>
</div>
</div>
<p><span id="more-8362"></span></p>
<p><img loading="lazy" class="alignnone wp-image-10705 size-large" src="https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-1024x632.jpg" alt="" width="847" height="523" srcset="https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-1024x632.jpg 1024w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-300x185.jpg 300w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-768x474.jpg 768w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-1536x948.jpg 1536w, https://www.biomedcode.com/wp-content/uploads/2023/08/TG5453-2048x1263.jpg 2048w" sizes="(max-width: 847px) 100vw, 847px" /></p>
<div class="page" title="Page 2">
<div class="section">
<div class="layoutArea">
<div class="column">
<p><span style="color: #808080;">Representative graph of the progression of the in vivo arthritic score in Tg5453 animals untreated or treated with commercially available anti-hTNF therapeutics.</span></p>
</div>
</div>
</div>
</div>
<p>&nbsp;</p>
<p><b>&nbsp;</b><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #7e95c5; color: #ffffff;" target="_blank" rel="noopener" href="https://www.biomedcode.com/wp-content/uploads/2019/08/Website2019_TgA5453-white-paper1.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/tga86-a-mouse-model-of-spondyloarthritis/">Tg5453: a mouse model of transmembrane TNF driven arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>The TNFΔARE Preclinical Platform for the preclinical  testing of therapeutics targeting rheumatoid arthritis and intestinal inflammation</title>
		<link>https://www.biomedcode.com/white-papers/the-tnf%ce%b4are-preclinical-platform-for-the-preclinical-testing-of-therapeutics-targeting-rheumatoid-arthritis-and-intestinal-inflammation/</link>
		
		<dc:creator><![CDATA[g y]]></dc:creator>
		<pubDate>Wed, 17 Apr 2019 13:57:48 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[arthritis]]></category>
		<category><![CDATA[IBD]]></category>
		<guid isPermaLink="false">http://biomedcodewp.generation-y.net/?p=8358</guid>

					<description><![CDATA[<p>The TNFΔARE mouse model develops arthritis pathology together with Crohn&#8217;s like ileal inflammation with 100% penetrance. The co-occurence of two inflammatory pathologies provide a reliable in-vivo model for evaluating therapeutics targeting both pathologies. Grip strength force modulation with age in wt and TNFΔARE mice treated or not with Enbrel&#160; &#160; Download the whitepaper to learn &#8230; <a href="https://www.biomedcode.com/white-papers/the-tnf%ce%b4are-preclinical-platform-for-the-preclinical-testing-of-therapeutics-targeting-rheumatoid-arthritis-and-intestinal-inflammation/" class="more-link">Continue reading <span class="screen-reader-text">The TNFΔARE Preclinical Platform for the preclinical  testing of therapeutics targeting rheumatoid arthritis and intestinal inflammation</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/the-tnf%ce%b4are-preclinical-platform-for-the-preclinical-testing-of-therapeutics-targeting-rheumatoid-arthritis-and-intestinal-inflammation/">The TNFΔARE Preclinical Platform for the preclinical  testing of therapeutics targeting rheumatoid arthritis and intestinal inflammation</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span style="color: #000000;">The TNFΔARE mouse model develops arthritis pathology together with Crohn&#8217;s like ileal inflammation with 100% penetrance. The co-occurence of two inflammatory pathologies provide a reliable in-vivo model for evaluating therapeutics targeting both pathologies.</span><span id="more-8358"></span></p>
<p><a href="https://www.biomedcode.com/wp2/"><img loading="lazy" class="alignnone size-full wp-image-8361" src="https://www.biomedcode.com/wp-content/uploads/2019/04/WP2.png" alt="" width="493" height="418" srcset="https://www.biomedcode.com/wp-content/uploads/2019/04/WP2.png 493w, https://www.biomedcode.com/wp-content/uploads/2019/04/WP2-300x254.png 300w" sizes="(max-width: 493px) 100vw, 493px" /></a></p>
<p><span style="color: #808080;">Grip strength force modulation with age in wt and TNFΔARE mice treated or not with Enbrel&nbsp;</span></p>
<p>&nbsp;</p>
<p><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #33809e; color: #ffffff;" target="_blank" rel="noopener" href="https://www.biomedcode.com/wp-content/uploads/2019/07/Website2019_TNF-DARE-white-paper010219-1.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/the-tnf%ce%b4are-preclinical-platform-for-the-preclinical-testing-of-therapeutics-targeting-rheumatoid-arthritis-and-intestinal-inflammation/">The TNFΔARE Preclinical Platform for the preclinical  testing of therapeutics targeting rheumatoid arthritis and intestinal inflammation</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Human TNF transgenic mouse arthritis model for the preclinical  testing of human therapeutics targeting rheumatoid arthritis</title>
		<link>https://www.biomedcode.com/white-papers/human-tnf-transgenic-mouse-arthritis-model-for-the-preclinical-testing-of-human-therapeutics-targeting-rheumatoid-arthritis/</link>
		
		<dc:creator><![CDATA[g y]]></dc:creator>
		<pubDate>Fri, 22 Mar 2019 11:41:56 +0000</pubDate>
				<category><![CDATA[White papers]]></category>
		<category><![CDATA[adalimumab]]></category>
		<category><![CDATA[arthritis]]></category>
		<category><![CDATA[etanercept]]></category>
		<category><![CDATA[infliximab]]></category>
		<category><![CDATA[therapeutic efficacy]]></category>
		<guid isPermaLink="false">http://biomedcodewp.generation-y.net/?p=8084</guid>

					<description><![CDATA[<p>The Tg197 mouse model was successfully used in establishing the therapeutic efficacy of Remicade®, the first anti-TNF therapeutic to be successfully applied in the clinic, and is recommended by the FDA for screening potential anti-rheumatoid candidate drugs. Tg197 is a transgenic mouse overexpressing human TNF resulting in the spontaneous development of arthritis whose pathology closely &#8230; <a href="https://www.biomedcode.com/white-papers/human-tnf-transgenic-mouse-arthritis-model-for-the-preclinical-testing-of-human-therapeutics-targeting-rheumatoid-arthritis/" class="more-link">Continue reading <span class="screen-reader-text">Human TNF transgenic mouse arthritis model for the preclinical  testing of human therapeutics targeting rheumatoid arthritis</span></a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/human-tnf-transgenic-mouse-arthritis-model-for-the-preclinical-testing-of-human-therapeutics-targeting-rheumatoid-arthritis/">Human TNF transgenic mouse arthritis model for the preclinical  testing of human therapeutics targeting rheumatoid arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><span style="color: #000000;">The Tg197 mouse model was successfully used in establishing the therapeutic efficacy of Remicade®, the first anti-TNF therapeutic to be successfully applied in the clinic, and is recommended by the FDA for screening potential anti-rheumatoid candidate drugs. </span></p>
<p><span style="color: #000000;">Tg197 is a transgenic mouse overexpressing human TNF resulting in the spontaneous development of arthritis whose pathology closely resembles human rheumatoid arthritis.&nbsp;The mice develop arthritis with 100% penetrance and provide a fast in-vivo model for evaluating human therapeutics targeting rheumatoid arthritis.</span></p>
<p><span id="more-8084"></span></p>
<p><img loading="lazy" class="alignnone wp-image-10727 size-large" src="https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-1024x662.jpg" alt="" width="847" height="548" srcset="https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-1024x662.jpg 1024w, https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-300x194.jpg 300w, https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-768x496.jpg 768w, https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-1536x993.jpg 1536w, https://www.biomedcode.com/wp-content/uploads/2023/08/Tg197-2048x1323.jpg 2048w" sizes="(max-width: 847px) 100vw, 847px" /></p>
<p><span style="color: #000000;">Download the whitepaper to learn more on:</span></p>
<ul>
<li><span style="color: #000000;">The disease model</span></li>
<li><span style="color: #000000;">Study design</span></li>
<li><span style="color: #000000;">Routes of administration</span></li>
<li><span style="color: #000000;">Validation data</span></li>
<li><span style="color: #000000;">Readouts</span></li>
<li><span style="color: #000000;">Analysis options</span></li>
</ul>
<p><a class="fasc-button fasc-size-medium fasc-type-flat fasc-ico-before dashicons-download" style="background-color: #33809e; color: #ffffff;" href="https://www.biomedcode.com/wp-content/uploads/2020/12/Website2019_Tg197-white-paper_20201218.pdf">DOWNLOAD PDF</a></p>
<p>The post <a rel="nofollow" href="https://www.biomedcode.com/white-papers/human-tnf-transgenic-mouse-arthritis-model-for-the-preclinical-testing-of-human-therapeutics-targeting-rheumatoid-arthritis/">Human TNF transgenic mouse arthritis model for the preclinical  testing of human therapeutics targeting rheumatoid arthritis</a> appeared first on <a rel="nofollow" href="https://www.biomedcode.com">Biomedcode</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
